Featuring one-on-one interviews conducted by Dr Neil Love, this program is designed to assist oncology clinicians with the evidence-based formulation of lung cancer treatment algorithms and provide access to patient perspectives that may facilitate the delivery of high-quality empathetic care.
Lung Cancer Update for Patients
Claim This Podcast8 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Featuring one-on-one interviews conducted by Dr Neil Love, this program is designed to assist oncology clinicians with the evidence-based formulation of lung cancer treatment algorithms and provide access to patient perspectives that may facilitate the delivery of high-quality empathetic care.
Language
🇺🇲
Publishing Since
10/15/2009
1 verified contact email on file for Lung Cancer Update for Patients
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
October 15, 2009
LCUP1 2009 | Interview with Heather Wakelee, MD
ResearchToPractice.com/NLCP2009 – Adjuvant Systemic Treatment of Non-Small Cell Lung Cancer — A Patient and Clinician Education Program on Treatment Options and Ongoing Clinical Trials. Interview with Heather Wakelee, MD conducted by Neil Love, MD. Produced by Research To Practice.
October 15, 2009
LCUP1 2009 | Interview with Joan H Schiller, MD
ResearchToPractice.com/NLCP2009 – Adjuvant Systemic Treatment of Non-Small Cell Lung Cancer — A Patient and Clinician Education Program on Treatment Options and Ongoing Clinical Trials. Interview with Joan H Schiller, MD conducted by Neil Love, MD. Produced by Research To Practice.
October 15, 2009
LCUP1 2009 | Interview with Patient 1
ResearchToPractice.com/NLCP2009 – Adjuvant Systemic Treatment of Non-Small Cell Lung Cancer — A Patient and Clinician Education Program on Treatment Options and Ongoing Clinical Trials. Interview with Patient 1 conducted by Neil Love, MD. Produced by Research To Practice.
8 total episodes available
Similar Podcasts
Discover related shows you might enjoy
Deep-dive analytics for Lung Cancer Update for Patients
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Lung Cancer Update for Patients?
- How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 2 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.